Amgen logo
Amgen AMGN
$ 338.69 -0.43%

Annual report 2025
added 02-13-2026

report update icon

Amgen Operating Cycle 2011-2026 | AMGN

Annual Operating Cycle Amgen

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
282 311 395 329 292 283 364 317 306 291 261 265 382 396 441

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
441 261 328

Quarterly Operating Cycle Amgen

2023-Q3 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
329 - - - 321 - 297 289 311 - 292 305 289 - 380 386 345 - 314 316 335 - 312 303 53.5 - 49.7 50.8 50.9 - 47.8 50.9 50.2 - 46.2 44.9 52.9 - 51.8 52.6 56.1 - 53.2 51.3 61 - 67 66.8 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
386 44.9 179

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.89 $ 0.89 -0.61 % $ 6.54 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
332 $ 22.43 0.58 % $ 3.72 B usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
135 - - $ 35.4 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
ChromaDex Corporation ChromaDex Corporation
CDXC
24.7 - -0.88 % $ 598 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
59 - 17.91 % $ 11.1 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
223 $ 4.08 -0.49 % $ 436 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
291 $ 22.98 -1.88 % $ 2.92 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
129 $ 1.48 4.23 % $ 394 M britainBritain
AstraZeneca PLC AstraZeneca PLC
AZN
206 - - $ 96.9 B britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
127 - - $ 546 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.69 -1.74 % $ 113 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
90.1 - - $ 1.2 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
1.66 K $ 1.07 -1.83 % $ 13.1 M usaUSA